Example: biology

BY ORDER OF THE AIR FORCE INSTRUCTION 90-507 …

BY ORDER OF THE AIR FORCE INSTRUCTION 90-507 . SECRETARY OF THE AIR FORCE . 22 SEPTEMBER 2014. Certified Current 18 December 2015. Special Management MILITARY drug DEMAND REDUCTION. PROGRAM. COMPLIANCE WITH THIS PUBLICATION IS MANDATORY. ACCESSIBILITY: Publications and forms are available on the e-publishing website at for downloading or ordering. RELEASABILITY: There are no releasability restrictions on the publication. OPR: AFMOA/SGB Certified by: SG/CC (Brig Charles Potter). Pages: 93. Supersedes: AFI44-120, 3 January 2011. This INSTRUCTION implements AFPD 90-5, Community Action and Information Board, Department of Defense Directive (DoDD) , Military Personnel drug Abuse testing Program, and Department of Defense INSTRUCTION (DoDI) , Technical Procedures for the Military Personnel drug Abuse testing Program, and prescribes the Air FORCE drug testing Program.

4 afi90-507 22 september 2014 attachment 8—drug urinalysis specimen packaging/shipping checklist 71 attachment 9—table a9.1 adod discrepancy codes 72 attachment 10—sample dd form 2624, specimen custody document drug testing 74 attachment 11—specimen packaging (box of 12) 76 attachment 12—single test kit (stk) packaging 81

Tags:

  Drug, Testing, Drug testing

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of BY ORDER OF THE AIR FORCE INSTRUCTION 90-507 …

1 BY ORDER OF THE AIR FORCE INSTRUCTION 90-507 . SECRETARY OF THE AIR FORCE . 22 SEPTEMBER 2014. Certified Current 18 December 2015. Special Management MILITARY drug DEMAND REDUCTION. PROGRAM. COMPLIANCE WITH THIS PUBLICATION IS MANDATORY. ACCESSIBILITY: Publications and forms are available on the e-publishing website at for downloading or ordering. RELEASABILITY: There are no releasability restrictions on the publication. OPR: AFMOA/SGB Certified by: SG/CC (Brig Charles Potter). Pages: 93. Supersedes: AFI44-120, 3 January 2011. This INSTRUCTION implements AFPD 90-5, Community Action and Information Board, Department of Defense Directive (DoDD) , Military Personnel drug Abuse testing Program, and Department of Defense INSTRUCTION (DoDI) , Technical Procedures for the Military Personnel drug Abuse testing Program, and prescribes the Air FORCE drug testing Program.

2 It assigns responsibility for carrying out the program at the installation level. This INSTRUCTION applies to all Regular Air FORCE (RegAF) members, Air Reserve Component (ARC) members, applicants for the Air FORCE Academy, Advanced Reserve Officers' Training Corps (ROTC), regular Armed Forces, appointment or enlistment (or re-enlistment if discharged more than 6. months earlier) into Active or Reserve Components, and Air National Guard (ANG) members on AGR (Active Guard Reserve) status, Title 10 status (when activated longer than 30 days), or on Personnel Reliability Program (PRP) status. The authorities to waive wing/unit level requirements in this publication are identified with a Tier ( T-0, T-1, T-2, T-3 ) number following the compliance statement. See AFI 33-360, Publications and Forms Management, Table for a description of the authorities associated with the Tier numbers.

3 Submit requests for waivers through the chain of command to the appropriate Tier waiver approval authority, or alternately, to the Publication OPR for non-tiered compliance items. This publication may be supplemented at any level, but all direct Supplements must be routed to the OPR of this publication for coordination prior to certification and approval. This Directive sets forth policies regarding drug demand reduction activities of Air FORCE military personnel, including the Air FORCE Reserve and Air National Guard. Failure to observe prohibitions and mandatory provisions of this directive may result in administrative disciplinary action. Violations may result in enhanced punishment under Article 92(1) of the UCMJ for violations, and members may be found to have violated Article 92(1) regardless of their knowledge of the requirements established by the publication.

4 Failure to observe the prohibitions and mandatory provisions in 2 AFI90-507 22 SEPTEMBER 2014. paragraphs and of this publication by military members is a violation of Article 92 of the UCMJ. This INSTRUCTION requires the collection and maintenance of information protected by the Privacy Act of 1974. System of Record Notice (SORN) F044 AF SG applies. Ensure that all records created as a result of processes prescribed in this publication are maintained in accordance with (IAW) Air FORCE Manual (AFMAN) 33-363, Management of Records, and disposed of IAW Air FORCE Record Disposition Schedule (RDS) located in the Air FORCE Records Information Management System (AFRIMS). The use of the name or mark of any specific manufacturer, commercial product, commodity, or service in this publication does not imply endorsement by the Air FORCE . Send comments and suggested improvements using the AF Form 847, Recommendation for Change of Publication, through channels, to AFMOA/SGHW, 2261.

5 Hughes Ave, Suite 153, JBSA Lackland, TX 78236-1025. SUMMARY OF CHANGES. This new revision updates responsibilities of the DDR personnel, changes in some testing procedures, and changes in supervision of the DDRP. Chapter 1 PROGRAM OVERVIEW 5. Overview.. 5. Goals and Objectives of the drug Demand Reduction Program.. 5. Levels and Frequency of testing .. 7. Chapter 2 ROLES AND RESPONSIBILITIES 9. Assistant Secretary of the Air FORCE for Manpower and Reserve Affairs (SAF/MR) .. 9. The Air FORCE Surgeon General (AF/SG) is the Office of Primary Responsibility (OPR) for the implementation of policy and guidance on AF drug testing .. 9. The Deputy Chief of Staff for Manpower and Personnel (AF/A1) .. 9. Air FORCE Medical Operations Agency (AFMOA).. 9. The Judge Advocate General (AF/JA).. 12. MAJCOMs.. 12. Chapter 3 GUIDANCE AND PROCEDURES 31. Chain of Custody for Collecting and Transporting Urine Specimens.

6 31. Chapter 4 FORM COMPLETION AND SPECIMEN PACKING REQUIREMENTS 37. Completion of the DD Form 2624, Specimen Custody Document - drug testing .. 37. Packaging and Shipping of Specimens.. 39. AFI90-507 22 SEPTEMBER 2014 3. Acceptable Modes of Transportation.. 41. Packaging And Shipping Of Specimens Collected In Single Test Kits (STKs). And Collection By Geographically Separated Units.. 41. Completion of the Chain of Custody Form, DD Form 2624, for Single Test Kit (STK).. 42. Packaging and Shipment of STK Specimens.. 42. Chapter 5 drug URINALYSIS testing FOR NEW ACCESSIONS 45. Personnel to be Tested.. 45. Timing of testing .. 45. drug testing Policy.. 46. Chapter 6 drug testing LABORATORY CHAIN OF CUSTODY PROCEDURES 47. Chain of Custody Requirements During Analysis.. 47. Laboratory Chain of Custody Requirements After Analysis.. 48. Chapter 7 ADDITIONAL PROCEDURES 49.

7 drug Detection Levels and Reporting Procedures.. 49. drug testing Laboratory Procedures.. 50. Supplies.. 52. drug testing Report Requirements/ drug testing Metrics.. 53. Use Of Urinalysis Results.. 53. Table Actions Authorized by Positive drug Test Results.. 54. Inability To Provide A Urine Specimen.. 55. Demand Reduction Outreach Activities And Use Of Appropriated Funds (outreach activities are optional based on funding)/Financial Management Activities.. 55. Attachment 1 GLOSSARY OF REFERENCES AND SUPPORTING INFORMATION 57. Attachment 2 SAMPLE FORMAT INSTALLATION LEVEL TRAINING MANUAL 63. Attachment 3 SAMPLE COLLECTION SITE CHECKLIST 64. Attachment 4 SAMPLE LETTER drug testing OBSERVER'S BRIEFING 66. Attachment 5 SAMPLE LETTER COMMANDER'S NOTIFICATION OF. SELECTION TO PROVIDE URINE SPECIMEN 68. Attachment 6 SAMPLE LETTER REQUESTING STEROID testing 69. Attachment 7 ORDERING BOTTLE LABELS 70.

8 4 AFI90-507 22 SEPTEMBER 2014. Attachment 8 drug URINALYSIS SPECIMEN PACKAGING/SHIPPING. CHECKLIST 71. Attachment 9 TABLE ADOD DISCREPANCY CODES 72. Attachment 10 SAMPLE DD FORM 2624, SPECIMEN CUSTODY DOCUMENT drug . testing 74. Attachment 11 SPECIMEN PACKAGING (BOX OF 12) 76. Attachment 12 SINGLE TEST KIT (STK) PACKAGING 81. Attachment 13 SAMPLE LETTER CERTIFICATION STATEMENT FOR. INDIVIDUAL 86. Attachment 14 SAMPLE LETTER DDRPM UNTESTABLE DISCREPANCY REPORT 87. Attachment 15 GUIDELINES FOR FORENSIC DOCUMENTATION 89. Attachment 16 GUIDELINES FOR drug DEMAND REDUCTION PROGRAM. (DDRP) FACILITIES 92. Attachment 17 SAMPLE LETTER DDR QURATERLY INSPECTION MEETING 93. AFI90-507 22 SEPTEMBER 2014 5. Chapter 1. PROGRAM OVERVIEW. Overview. The drug Demand Reduction Program (DDRP) directly impacts mission readiness. The success of this long-standing program can be traced directly to strong command support at all levels.

9 Illicit drug Use. The Air FORCE does not tolerate the illegal or improper use of drugs by Air FORCE personnel. Such use: Is a serious breach of discipline. Is not compatible with service in the Air FORCE . Automatically places the member's continued service in jeopardy. Can lead to criminal prosecution resulting in a punitive discharge or administrative actions, including separation or discharge under other than honorable conditions. Studies have shown that products made with hemp seed and hemp seed oil may contain varying levels of tetrahydrocannabinol (THC), an active ingredient of marijuana, which is detectable under the Air FORCE drug testing Program. In ORDER to ensure military readiness, the ingestion of products containing or products derived from hemp seed or hemp seed oil is prohibited. Failure to comply with the mandatory provisions of this paragraph by military personnel is a violation of Article 92, UCMJ.

10 Violations may result in administrative disciplinary action without regard to otherwise applicable criminal or civil sanctions for violations of related laws. In ORDER to ensure military readiness; safeguard the health and wellness of the FORCE , and maintain good ORDER and discipline in the service, the knowing use of any intoxicating substance, other than the lawful use of alcohol or tobacco products, that is inhaled, injected, consumed, or introduced into the body in any manner to alter mood or function is prohibited. These substances include, but are not limited to, controlled substance analogues ( , designer drugs such as "spice" that are not otherwise controlled substances); inhalants, propellants, solvents, household chemicals, and other substances used for "huffing";. prescription or over-the-counter medications when used in a manner contrary to their intended medical purpose or in excess of the prescribed dosage; and naturally occurring intoxicating substances ( , Salvia divinorum).


Related search queries